Tempus AI shareholder Andrew Polovin plans $206K sale
A Tempus AI, Inc. executive filed a Rule 144 notice to sell 2,951 RSU-derived common shares, following earlier 10b5-1 sales of 7,927 shares.
Rhea-AI Filing Summary
Tempus AI, Inc. (TEM) is the issuer for a Rule 144 notice filed by Andrew Polovin covering a proposed sale of 2,951 shares of common stock. These shares arise from Restricted Stock Units granted on May 20, 2025 and are to be sold through Morgan Stanley Smith Barney LLC on NASDAQ.
Over the prior three months, Polovin reported 10b5-1 sales of 7,927 common shares on August 19, 2026 with total proceeds of $443,912.00, providing context for the aggregation of sales under Rule 144.
Positive
- None.
Negative
- None.
Key Figures
Key Terms
Rule 144 regulatory
Restricted Stock Units financial
10b5-1 Sales regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What type of Tempus AI (TEM) security is involved in this Form 144?
The security is common stock of Tempus AI, Inc., arising from Restricted Stock Units. The RSUs are shown with a grant date of May 20, 2025, and the resulting 2,951 common shares are the securities to be sold under Rule 144.
Is there a trading plan associated with the Tempus AI (TEM) insider’s recent sales?
Yes. The section on securities sold during the past three months describes “10b5-1 Sales for Andrew Polovin”, reporting the sale of 7,927 common shares on August 19, 2026 for $443,912.00, indicating those sales were made under a Rule 10b5-1 plan.
AI-generated analysis. How Rhea-AI works. Not financial advice.